onkoserv

Indikation: Kopf- und Hals- Tumore

zurück

2012

ARIX: A randomised trial of acupuncture v oral care sessions in patients with chronic xerostomia following treatment of head and neck cancer

Ann Oncol 23 (2012) Online first 25. 10. 2012

Phase II study of figitumumab in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck: clinical activity and molecular response (GORTEC 2008-02)

Ann Oncol 23 (2012) 2153-2163

Pemetrexed in combination with cisplatin versus cisplatin monotherapy in patients with recurrent or metastatic head and neck cancer

Cancer 118 (2012) 4694-4705

Phase II trial of induction chemotherapy followed by surgery for squamous cell carcinoma of the oral tongue in young adults

Head Neck 34 (2012) 1255-1262

Phase II study of the combination of cetuximab and weekly paclitaxel in the first-line treatment of patients with recurrent and/or metastatic squamous cell carcinoma of head and neck

Ann Oncol 23 (2012) 1016-1022

Re-irradiation combined with capecitabine in locally recurrent squamous cell carcinoma of the head and neck. A prospective phase II trial

Strahlenther Onkol 188 (2012) 235-242

A phase II study of gefitinib for aggressive cutaneous squamous cell carcinoma of the head and neck

Clin Cancer Res 18 (2012) 1435-1446

Long-term Follow-up of the RTOG 9501/Intergroup Phase III Trial: Postoperative Concurrent Radiation Therapy and Chemotherapy in High-Risk Squamous Cell Carcinoma of the Head and Neck

Int J Rad Oncol Biol Phys 83 (2012) Online first 30. 6. 2012

Phase II Study of Gemcitabine and Docetaxel Combination in Patients with Previously Treated Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck

ISRN Oncol 2012 (2012) 159568

Intensity-Modulated Radiation Therapy with Concurrent Carboplatin and Paclitaxel for Locally Advanced Head and Neck Cancer: Toxicities and Efficacy

Oncologist 17 (2012) 673-681

Randomized controlled trial of acupuncture for prevention of radiation-induced xerostomia among patients with nasopharyngeal carcinoma

Cancer 118 (2012) 3337-3347

Induction chemotherapy followed by concomitant radiotherapy and weekly cisplatin versus the same concomitant chemoradiotherapy in patients with nasopharyngeal carcinoma: a randomized phase II study conducted by the Hellenic Cooperative Oncology Group (HeCOG) with biomarker evaluation

Ann Oncol 23 (2012) 427-435

Accelerated Radiotherapy With Carbogen and Nicotinamide for Laryngeal Cancer: Results of a Phase III Randomized Trial

J Clin Oncol 30 (2012) 1777-1783

A prospective protocol for nasopharyngeal carcinoma in children and adolescents

Cancer 118 (2012) 2718-2725

Quality of life scores as prognostic factors of overall survival in advanced head and neck cancer: Analysis of a phase III randomized trial of pemetrexed plus cisplatin versus cisplatin monotherapy

Oral Oncol 38 (2012) Online first 11. 3. 2012

Phase II Study Evaluating the Addition of Cetuximab to the Concurrent Delivery of Weekly Carboplatin, Paclitaxel, and Daily Radiotherapy for Patients With Locally Advanced Squamous Cell Carcinomas of the Head and Neck

Int J Rad Oncol Biol Phys 82 (2012) 1845-1850

Phase 2 trial of oxaliplatin and pemetrexed as an induction regimen in locally advanced head and neck cancer

Cancer 118 (2012) 1007-1013

Concomitant chemoradiotherapy versus acceleration of radiotherapy with or without concomitant chemotherapy in locally advanced head and neck carcinoma (GORTEC 99-02): an open-label phase 3 randomised trial

Lancet Oncol 13 (2012) 145-153

Concomitant Cisplatin and Hyperfractionated Radiotherapy in Locally Advanced Head and Neck Cancer: 10-Year Follow-Up of a Randomized Phase III Trial (SAKK 10/94)

Int J Rad Oncol Biol Phys 82 (2012) 524 531
2011

Efficacy of capecitabine versus 5-fluorouracil in colorectal and gastric cancers: a meta-analysis of individual data from 6171 patients

Ann Oncol 22 (2011) 2604-2609